Financials data is unavailable for this security.
View more
Year on year Instituto de Diagnostico SA had net income fall -98.89% from 13.05bn to 144.31m despite a 14.45% increase in revenues from 191.29bn to 218.93bn. An increase in the cost of goods sold as a percentage of sales from 76.21% to 79.50% was a component in the falling net income despite rising revenues.
| Gross margin | 23.42% |
|---|---|
| Net profit margin | 2.33% |
| Operating margin | 5.02% |
| Return on assets | 1.97% |
|---|---|
| Return on equity | 5.15% |
| Return on investment | 2.86% |
More ▼
Cash flow in CLPView more
In 2023, cash reserves at Instituto de Diagnostico SA fell by 1.43bn. However, the company earned 21.03bn from its operations for a Cash Flow Margin of 9.61%. In addition the company used 5.28bn on investing activities and also paid 17.18bn in financing cash flows.
| Cash flow per share | 103.50 |
|---|---|
| Price/Cash flow per share | 13.53 |
| Book value per share | 755.09 |
|---|---|
| Tangible book value per share | 691.17 |
More ▼
Balance sheet in CLPView more
| Current ratio | 1.19 |
|---|---|
| Quick ratio | 1.15 |
| Total debt/total equity | 1.03 |
|---|---|
| Total debt/total capital | 0.5085 |
More ▼
Growth rates in CLP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -62.02% and -98.89%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.61% |
|---|---|
| Div growth rate (5 year) | -8.01% |
| Payout ratio (TTM) | 0.81% |
| EPS growth(5 years) | -60.33 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 725.80 |
More ▼
